Search Results - "Idato, Aurora"

Effectiveness of biosimilar pegfilgrastim in patients with lymphoma after high-dose chemotherapy and autologous stem cell transplantation: a real-life study by Loteta, Barbara, Pitino, Annalisa, Pitea, Martina, Alati, Caterina, Tripepi, Giovanni, Mico', Maria Caterina, Pellicano', Maria, Cogliandro, Francesca, Porto, Gaetana, Policastro, Giorgia, Utano, Giovanna, Delfino, Ilaria Maria, Sgarlata, Annalisa, Scopelliti, Anna, Idato, Aurora, Laenza, Giovanni, Altomonte, Maria, D'Arrigo, Graziella, Gori, Mercedes, Martino, Massimo

“…Objectives To evaluate the efficacy of biosimilar (BIO) pegfilgrastim (PEG) in lymphoma patients after autologous stem cell transplantation (ASCT). Methods 86…”
Get full text

P-388 Clinical Efficacy of Isatuximab Plus Carfilzomib-Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: An Italian Real-Life Multi-Center Retrospective Experience by De Novellis, Danilo, Derudas, Daniele, Fontana, Raffaele, Vincelli, Iolanda Donatella, Pepa, Roberta Della, Palmieri, Salvatore, Accardi, Fabrizio, Rotondo, Francesco, Morelli, Emanuela, Roccotelli, Daniela, Marano, Luana, Barone, Maria Lucia, Esposito, Daniela, Gigliotta, Emilia, Bianco, Rosario, Lazzaro, Antonio, Serio, Bianca, Rocco, Stefano, Idato, Aurora, Leone, Aldo, Falcone, Antonietta Pia, Marcacc, Gianpaolo, Giudice, Valentina, Botta, Cirino, Selleri, Carmine

Get full text

First-Line Use of Daratumumab in Patients with Multiple Myeloma Shows Delayed Neutrophil and Platelet Engraftment after Autologous Stem Cell Transplantation: Results from a Real-Life Single-Center Study by Martino, Massimo, Gori, Mercedes, Porto, Gaetana, Policastro, Giorgia, Pitea, Martina, Sgarlata, Annalisa, Delfino, Ilaria Maria, Cogliandro, Francesca, Scopelliti, Anna, Utano, Giovanna, Pellicano, Maria, Idato, Aurora, Vincelli, Iolanda Donatella, Marafioti, Violetta, Micò, Maria Caterina, Lazzaro, Giuseppe, Loteta, Barbara, Alati, Caterina, Leanza, Giovanni, D'Arrigo, Graziella, Tripepi, Giovanni Luigi, Pitino, Annalisa

“…This real-life study aimed to investigate the possible impact of D-VTd induction therapy on hematopoietic engraftment after autologous stem cell…”
Get full text

Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients by De Novellis, Danilo, Derudas, Daniele, Vincelli, Donatella, Fontana, Raffaele, Della Pepa, Roberta, Palmieri, Salvatore, Accardi, Fabrizio, Rotondo, Francesco, Morelli, Emanuela, Gigliotta, Emilia, Roccotelli, Daniela, Marano, Luana, Barone, Maria Lucia, Cetani, Giusy, Esposito, Daniela, Lazzaro, Antonio, Delle Cave, Giuseppe, Serio, Bianca, Morini, Denise, Porrazzo, Marika, Urciuoli, Eleonora, Masucci, Chiara, Fanelli, Fulvia, Rizzo, Michela, Arcamone, Manuela, Trastulli, Fabio, Rocco, Stefano, Leone, Aldo, Bianco, Rosario, Salvatore, Flavia, Idato, Aurora, Sicari, Maria, Tosi, Patrizia, Rascato, Maria Gabriella, Di Perna, Maria, Falcone, Antonietta Pia, Morello, Lucia, Carlisi, Melania, Svanera, Gino, Annunziata, Mario, Frigeri, Ferdinando, Califano, Catello, Carella, Angelo Michele, Marcacci, Gianpaolo, Pane, Fabrizio, Risitano, Antonio Maria, Giudice, Valentina, Botta, Ciro, Selleri, Carmine

“…Isatuximab, a novel anti-CD38 monoclonal antibody, is approved in combination with carfilzomib and dexamethasone (Isa-Kd) in relapsed/refractory multiple…”
Get full text